Skip to content

A Retrospective, Multicenter, Controlled Clinical Trail: to Evaluate the Efficiency and Safety of Intracranial Aneurysm Assistive Software in the Preoperative Assessment

A Retrospective, Multicenter, Controlled Clinical Trail: to Evaluate the Efficiency and Safety of Intracranial Aneurysm Assistive Software in the Preoperative Assessment

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05651425
Enrollment
600
Registered
2022-12-15
Start date
2022-12-20
Completion date
2023-04-30
Last updated
2022-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Aneurysm

Keywords

intracranial aneurysm, intravascular coiling embolization

Brief summary

the goal of this clinical trail is to evaluate the efficiency and safety of intracranial aneurysm assistive software in the preoperative assessment. The trail is designed as retrospective, multicenter, controlled clinical trail. Collecting probable cases images retrospectively according to inclusion criteria and exclusion criteria strictly. Controlling bias strictly, to make sure the efficiency and safety of intracranial aneurysm assistive software is evaluated reliably and precisely. In our trail, software-assisstant planning controls against experienced-surgeon-independent planning,which aims to avoid bias effictively and eliminate non-test interferences.

Interventions

None listed

Sponsors

RenJi Hospital
CollaboratorOTHER
Shanxi Provincial People's Hospital
CollaboratorOTHER_GOV
Beijing Tiantan Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. aged 18-80y, no gender limitation. 2. non-ruptured intracranial saccular aneurysm with specific intracranial CTA images; Target aneurysm has performed intravascular coiling treatment. 3. intracranial aneurysm diameter range from 3mm to 10mm. 4. the shape of aneurysm is regular without daughter sac or more than 2 lobulations. Inclusion criteria of images: 1. the number of detector rows of Computed Tomography(CT) is more than 16 rows. 2. slice thickness ≤ 0.625mm, whole-brain image is considered. 3. Both plain scan sequences and enhancer sequence are required.

Exclusion criteria

1. combined with cerebral hemorrhage; 2. combined with cerevascular malformation or cerebral occupying lesion; 3. fusiform aneurysm or dissection aneurysm; 4. significant proximal stenosis of parent artery; 5. intracaverous internal carotid artery aneurysm; 6. target aneurysm has been performed flow-diverter stents treatment.

Design outcomes

Primary

MeasureTime frameDescription
concordance rateaccessment time point : immediately after computational coiling diameter assessment finished.the optimal coiling diameter used in surgery is considered as gold standard. The concordance rate is defined as computational suitable coiling diameter in test group differs gold standard less than ±1mm. concordance rate=the number of concordance matched/totle enrolled number\*100%

Secondary

MeasureTime frameDescription
coincidence rateaccessment time point: immediately after computational coiling diameter assessment finished.the optimal coiling diameter used in surgery is considered as gold standard. The coincidence rate is defined as computational suitable coiling diameter in test group is less than gold standard. coincidence rate= the number meets coincidence requirement /totle enrolled \*100%

Countries

China

Contacts

Primary ContactShuo Wang, MD
captain5868@162.com13801180330
Backup ContactQinyuan Liu, MD
13260457220@163.com13260457220

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026